Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.13 EUR
205.22 M EUR
1.48 B EUR
285.21 M
About PHARMARON BEIJING
Sector
CEO
Bo Liang Lou
Website
Headquarters
Beijing
Founded
2004
ISIN
CNE100003PG4
FIGI
Pharmaron Beijing Co., Ltd. engages in the provision of full-process integrated drug research, development, and production services from drug discovery to drug development. It provides laboratory, CMC, macromolecules and cell & gene therapy, and clinical research services. The company was founded by Bo Liang Lou, Xiao Qiang Lou and Bei Zheng on July 1, 2004 and is headquartered in Beijing, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 17Q1 is 1.69 EUR — it has decreased by −1.74% in the past 24 hours. Watch PHARMARON BEIJING CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange PHARMARON BEIJING CO., LTD. stocks are traded under the ticker 17Q1.
17Q1 stock has fallen by −10.58% compared to the previous week, the month change is a 6.96% rise, over the last year PHARMARON BEIJING CO., LTD. has showed a −31.85% decrease.
We've gathered analysts' opinions on PHARMARON BEIJING CO., LTD. future price: according to them, 17Q1 price has a max estimate of 2.92 EUR and a min estimate of 0.97 EUR. Watch 17Q1 chart and read a more detailed PHARMARON BEIJING CO., LTD. stock forecast: see what analysts think of PHARMARON BEIJING CO., LTD. and suggest that you do with its stocks.
17Q1 reached its all-time high on Oct 7, 2024 with the price of 2.82 EUR, and its all-time low was 0.90 EUR and was reached on Aug 22, 2024. View more price dynamics on 17Q1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
17Q1 stock is 1.78% volatile and has beta coefficient of 2.07. Track PHARMARON BEIJING CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is PHARMARON BEIJING CO., LTD. there?
Today PHARMARON BEIJING CO., LTD. has the market capitalization of 3.05 B, it has increased by 3.12% over the last week.
Yes, you can track PHARMARON BEIJING CO., LTD. financials in yearly and quarterly reports right on TradingView.
PHARMARON BEIJING CO., LTD. is going to release the next earnings report on Mar 31, 2025. Keep track of upcoming events with our Earnings Calendar.
17Q1 earnings for the last quarter are 0.02 EUR per share, whereas the estimation was 0.03 EUR resulting in a −23.19% surprise. The estimated earnings for the next quarter are 0.04 EUR per share. See more details about PHARMARON BEIJING CO., LTD. earnings.
PHARMARON BEIJING CO., LTD. revenue for the last quarter amounts to 405.01 M EUR, despite the estimated figure of 427.86 M EUR. In the next quarter, revenue is expected to reach 444.06 M EUR.
17Q1 net income for the last quarter is 38.76 M EUR, while the quarter before that showed 113.91 M EUR of net income which accounts for −65.97% change. Track more PHARMARON BEIJING CO., LTD. financial stats to get the full picture.
Yes, 17Q1 dividends are paid annually. The last dividend per share was 0.03 EUR. As of today, Dividend Yield (TTM)% is 1.58%. Tracking PHARMARON BEIJING CO., LTD. dividends might help you take more informed decisions.
PHARMARON BEIJING CO., LTD. dividend yield was 1.39% in 2023, and payout ratio reached 22.03%. The year before the numbers were 0.61% and 24.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 17, 2024, the company has 20.30 K employees. See our rating of the largest employees — is PHARMARON BEIJING CO., LTD. on this list?
Like other stocks, 17Q1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMARON BEIJING CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMARON BEIJING CO., LTD. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMARON BEIJING CO., LTD. stock shows the buy signal. See more of PHARMARON BEIJING CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.